Sterile Medical Packaging Global Market Report 2024

Sterile medical packaging is a method of enclosing medical goods using a single-use material to prevent the spread of microbes and minimize the risk of contamination. This packaging is designed to maintain sterility from the point of packaging until the moment of use.

The primary categories of sterile medical packaging include thermoformed trays, sterile bottles and containers, sterile closures, pre-fillable inhalers, pre-fillable syringes, vials and ampoules, blisters and clamshells, bags and pouches, and wraps. Various materials, such as plastics, glass, metal, and paper & paperboard, are utilized in the manufacturing of these packages. They find application in pharmaceutical and biological products, surgical and medical instruments, in-vitro diagnostic products, medical implants, and other related industries.

The sterile medical packaging market research report is one of a series of new reports that provides sterile medical packaging market statistics, including sterile medical packaging industry global market size, regional shares, competitors with a sterile medical packaging market share, detailed sterile medical packaging market segments, market trends and opportunities, and any further data you may need to thrive in the sterile medical packaging industry. This sterile medical packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sterile medical packaging market size has grown rapidly in recent years. It will grow from $47.82 billion in 2023 to $52.81 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The historical growth can be attributed to the expansion of the medical device industry, increased healthcare expenditure, the implementation of infection control measures, advancements in sterilization techniques, and a heightened awareness of infection control.

The sterile medical packaging market size is expected to see rapid growth in the next few years. It will grow to $82.22 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The anticipated growth in the forecast period is linked to factors such as the rise of biologics and biopharmaceuticals, an aging population, pharmaceutical serialization, emphasis on customization and sustainability, and the increasing presence of e-commerce in healthcare. Noteworthy trends in the forecast period include the adoption of advanced barrier materials, the implementation of RFID and track-and-trace technologies, the development of e-commerce packaging solutions, the incorporation of child-resistant packaging, and the utilization of tamper-evident packaging.

The rising prevalence of infectious diseases and viruses has generated a heightened demand for sterile medical packaging, aiming to prevent contamination. This surge is anticipated to significantly contribute to the market's growth. Infectious diseases, transferable between individuals or animals, have become a global concern, with the World Health Organization reporting 150 million confirmed COVID-19 cases and 3.1 million deaths worldwide in April 2021. The escalating number of infectious disease cases underscores the increased need for sterile medical packaging.

The growing count of hospitals is poised to drive the expansion of the sterile medical packaging market. Hospitals, dedicated to providing medical or surgical treatment, rely on sterile medical packaging as a crucial element to safeguard the safety and integrity of medical equipment and devices. In 2021, the United States alone had approximately 6,090 hospitals, with a global estimate of around 165,000 hospitals, as reported by Discovery Therapy, a US-based mental health care provider. Additionally, data from the American Hospital Association in May 2023 stated that there were 6,129 hospitals in the United States in 2022. This substantial increase in the number of hospitals is expected to fuel the growth of the sterile medical packaging market.

Major players in the sterile medical packaging market are actively developing sustainable solutions to meet the rising demand. These solutions focus on materials and practices that minimize waste and environmental impact while upholding product integrity and patient safety. An example is the launch of the AmSky blister system by Amcor PLC, an Australia-based packaging company, in April 2021. This thermoform blister packaging system utilizes recyclable polyethylene, replacing PVC and foil in the packaging process.

An emerging trend in the sterile medical packaging market is the adoption of environmentally friendly packaging. With a growing concern for waste and plastic pollution, pharmaceutical companies are increasingly embracing sustainable business practices and exploring packaging materials that are renewable and recyclable. AstraZeneca, in January 2021, launched a $1 billion sustainability plan with various initiatives, including sustainable packaging, aimed at reducing the carbon footprint by 2031.

In September 2022, the US-based specialty chemical company, Eastman Chemical Company, announced a strategic collaboration with Ethicon, Inc., a manufacturer of surgical sutures and wound closure devices. As a result of this collaboration, Ethicon became the first healthcare organization to integrate medical-grade Eastman Renew materials into its product packaging. This strategic move is instrumental in reducing waste within the healthcare system and advancing the principles of the circular economy.

Major companies operating in the sterile medical packaging market include Amcor Limited, DuPont De Nemours and Company, 3M Company, West Pharmaceutical Services Inc., Oliver Healthcare Packaging LLC, Placon Corporation, Oracle Packaging, Riverside Medical Packaging Company Ltd., Wipak Group., Steripack Ltd., BillerudKorsnäs, Techinipaq Inc., GS Medical Packaging Inc., Sonoco Products Company, Nelipak Healthcare Packaging, Januaryco Inc., Berry Global Inc., Gerresheimer AG, Schott AG, Sealed Air Corporation, Bemis Company Inc., Mitsubishi Chemical Holdings Corporation, UFP Technologies Inc., Huhtamaki Oyj, Klockner Pentaplast Group, Pregis LLC, Prent Corporation, Printpack Inc., Beacon Converters Inc., Perfecseal Inc., GVS Group, Vanrx Pharmasystems Inc., ProAmpac LLC, Tekni-Plex Inc., Constantia Flexibles Group GmbH, Nelipak Corporation

North America was the largest region in the sterile medical packaging market share in 2023. The regions covered in this global sterile medical packaging market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the sterile medical packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The sterile medical packaging market includes revenues earned by entities by sterilizing medical goods such as syringes, needles, vials, and medical instruments to protect from microbial contamination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.